![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Induction Healthcare Group Plc | LSE:INHC | London | Ordinary Share | GB00BJ0M3545 | ORD 0.5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 10.00 | 9.00 | 11.00 | 10.00 | 10.00 | 10.00 | 0.00 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Business Services, Nec | 12.88M | -17.38M | -0.1882 | -0.53 | 9.24M |
TIDMINHC
RNS Number : 1667I
Induction Healthcare Group PLC
12 April 2022
Induction Healthcare Group PLC
("Induction", the "Company", or the "Group")
Purchase of Shares by Director
Induction Healthcare (AIM: INHC), a leading digital health platform driving transformation of healthcare systems worldwide , announces that Andy Williams, Non-Executive Director, has today purchased 179,484 ordinary shares in the Company at 51.5 pence and following this Mr Williams holds 889,968 ordinary shares, representing 0.97 per cent. of the Company's current issued share capital.
In the announcement released at 7.00 a.m. today, Mr Williams' shareholding was incorrectly shown as 610,484 shares when it should have been 710,484 shares. Similarly, Dr Hugo Stephenson's shareholding was shown as 2,226,273 shares when it should have been 2,256,273 shares.
ENQUIRIES
Induction Via Walbrook PR Ltd: induction@walbrookpr.com James Balmain, Chief Executive Officer Guy Mitchell, Chief Financial Officer Singer Capital Markets (Nominated Adviser and Broker) +44 (0)20 7496 3000 Philip Davies / Kailey Aliyar Walbrook PR Ltd induction@walbrookpr.com Paul McManus / Alice Woodings Mob: +44(0)7980 541 893 / +44 (0)7407 804 654 About Induction - www.inductionhealthcare.com
Induction (AIM: INHC) Induction delivers a suite of software solutions through a single integrated platform that transforms care delivery. Our system-wide applications help healthcare providers and administrators to deliver care at any stage remotely as well as face-to-face - enabling a more flexible, efficient and positive experience for the communities they serve . Purpose built for integration with leading Electronic Medical Record (EMR) platforms, our products offer immediate stand-alone value that becomes even greater when integrated with pre-existing systems.
Used at scale by national and regional healthcare systems, as well non-health government services, our applications are relied upon by hundreds of thousands of clinicians and millions of patients across almost every hospital in the British Isles.
The information set out below is provided in accordance with the requirements of Article 19(3) of the EU Market Abuse Regulation No 596/2014
1. Details of the person discharging managerial responsibilities / person closely associated a. Name Andy Williams ---------------------------------- ------------------------------------- 2. Reason for the notification ------------------------------------------------------------------------- a. Position/status Non-Executive Director ---------------------------------- ------------------------------------- a. Initial notification Initial notification /Amendment ---------------------------------- ------------------------------------- 3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ------------------------------------------------------------------------- a. Name Induction Healthcare Group plc ---------------------------------- ------------------------------------- b. LEI 213800RY96GCZQW5TP19 ---------------------------------- ------------------------------------- 4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted ------------------------------------------------------------------------- a. Description Ordinary shares of 0.5 pence each of the Financial instrument, GB00BJ0M3545 type of instrument Identification code ---------------------------------- ------------------------------------- b. Nature of the Purchase of Ordinary Shares transaction ---------------------------------- ------------------------------------- c. Price(s) and 51.5 pence volume(s) 179,484 Ordinary Shares ---------------------------------- ------------------------------------- d. Aggregated N/A information * Aggregated volume * Price ---------------------------------- ------------------------------------- e. Date of the 12 April 2022 transaction ---------------------------------- ------------------------------------- f. Place of the London Stock Exchange transaction ---------------------------------- -------------------------------------
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHITMITMTABBLT
(END) Dow Jones Newswires
April 12, 2022 11:00 ET (15:00 GMT)
1 Year Induction Healthcare Chart |
1 Month Induction Healthcare Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions